Race appoints clinical and FDA regulatory strategy advisor
Race Oncology is pleased to announce that it has appointed the clinical and regulatory strategy…
Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.
ASX Announcements
Share Price
Latest News
Race team talks about new leadership model
Our executive leaders discuss the benefits of a shared leadership model and the experience they…
Race leadership team strengthened
1 September 2020 – Race Oncology Limited (ASX: RAC) is pleased to announce that it…
2020 Annual Report Summary
Dear Shareholders It is my pleasure to formally open the annual report to Race Oncology…
July 2020 Investor Update
Race Oncology is please update our shareholders on the clinical progress of bisantrene. This talk…
Race to present on 29 July at IRD Invest
22 July 2020 – Race Oncology Limited (ASX:RAC) is pleased to announce that Dr Daniel Tillett…
